Screener
Myriad Genetics MYGN Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$43.2M+86.9% | -$34.1M-34,000% | -$7.9M+81.4% | -$27.4M-24.0% | -$330.5M-801% | ||
| $12.5M-11.3% | $12.5M-13.2% | $12.6M-14.9% | $12.6M-19.2% | $14.1M-6.6% | ||
| $500K-95.3% | $6.5M-31.6% | $2.8M-74.3% | $12.2M-1.6% | $10.7M-26.2% | ||
| -$8.3M+39.0% | -$15.7M+3.7% | $10.6M— | $21.1M— | -$13.6M— | ||
| -$3.2M+53.6% | -$6.5M+21.7% | -$6M-1.7% | -$6.2M— | -$6.9M-7.8% | ||
| $0— | $0-100% | —— | —— | —— | ||
| $0— | $0-100% | —— | $60M+200% | —— | ||
| —— | -$3M-122% | —— | $56.2M+1,913% | $2.6M— | ||
| -$9.2M+46.8% | -$25.3M-132% | $0— | $71.1M— | -$17.3M-293% |
FAQ
- How much cash does Myriad Genetics generate?
- Myriad Genetics (MYGN) generated $7.7M in operating cash flow over the trailing twelve months.
- Where does Myriad Genetics's cash flow data come from?
- Every line is extracted from Myriad Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
